Search Results - "Gabbay, Eli"

Refine Results
  1. 1
  2. 2
  3. 3

    Pulmonary arterial hypertension outcomes upon endothelin-1 receptor antagonist switch to macitentan by Tynan, Timothy, Hird, Kathryn, Hannon, Tara, Gabbay, Eli

    Published in Journal of international medical research (01-05-2019)
    “…Objectives To assess whether switching patients with suboptimally controlled pulmonary arterial hypertension from bosentan or ambrisentan to macitentan would…”
    Get full text
    Journal Article
  4. 4

    The impact of the 2022 Ukraine/Russian conflict on cancer clinical trials by Talbot, Alice, Connor, Sophia G., Austin, Kate, Hannon, Tara, Gabbay, Eli, Clay, Timothy D.

    Published in Journal of International Medical Research (01-12-2022)
    “…Since the invasion of Ukraine in February 2022, clinical trial conduct has become extremely challenging due to damage to the healthcare infrastructure and…”
    Get full text
    Book Review Journal Article
  5. 5

    Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series by Picard, Sarah, Goh, Desiree, Tan, Ashley, Sikotra, Nisha, Gabbay, Eli, Clay, Tim

    Published in Journal of medical case reports (03-07-2021)
    “…Abstract Background Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including…”
    Get full text
    Journal Article
  6. 6

    Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study by Ngian, Gene-Siew, Stevens, Wendy, Prior, David, Gabbay, Eli, Roddy, Janet, Tran, Ai, Minson, Robert, Hill, Catherine, Chow, Ken, Sahhar, Joanne, Proudman, Susanna, Nikpour, Mandana

    Published in Arthritis research & therapy (05-10-2012)
    “…Pulmonary arterial hypertension (PAH) is a major cause of mortality in connective tissue disease (CTD). We sought to quantify survival and determine factors…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Time from symptoms to definitive diagnosis of idiopathic pulmonary arterial hypertension: The delay study by Strange, Geoff, Gabbay, Eli, Kermeen, Fiona, Williams, Trevor, Carrington, Melinda, Stewart, Simon, Keogh, Anne

    Published in Pulmonary circulation (01-01-2013)
    “…Survival rates for patients with idiopathic pulmonary arterial hypertension (IPAH) have improved with the introduction of PAH-specific therapies. However, the…”
    Get full text
    Journal Article
  10. 10

    Dilemmas in anticoagulation and use of inferior vena cava filters in venous thromboembolism; a survey of Respiratory Physicians, Haematologists and Medical Oncologists and a review of the literature by Craven, Philip, Daly, Ciara, Sikotra, Nisha, Clay, Tim, Gabbay, Eli

    Published in Pulmonary circulation (01-01-2021)
    “…Twenty percent of patients with Cancer Associated Thrombosis receive an inferior vena cava filter annually. Insertion is guided by practice guidelines, which…”
    Get full text
    Journal Article
  11. 11

    Inferior vena cava filters (IVCFs): a review of uses and application to international guidelines at a single Australian center; implications of venous thromboembolism associated with malignancy by Craven, Philip, Daly, Ciara, Oates, Randall, Sikotra, Nisha, Clay, Tim, Gabbay, Eli

    Published in Pulmonary circulation (01-04-2018)
    “…Venous thromboembolism (VTE) is a potentially lethal event. Anticoagulation is the cornerstone of treatment. Inferior vena cava filters (IVCFs) may be used in…”
    Get full text
    Journal Article
  12. 12

    Exercise Intolerance in Pulmonary Arterial Hypertension by Fowler, Robin M., Gain, Kevin R., Gabbay, Eli

    Published in Pulmonary Medicine (01-01-2012)
    “…Pulmonary arterial hypertension (PAH) is associated with symptoms of dyspnea and fatigue, which contribute to exercise limitation. The origins and significance…”
    Get full text
    Journal Article
  13. 13

    Quality of Life in Pulmonary Arterial Hypertension: Improvement and Maintenance With Bosentan by Keogh, Anne M., MD, McNeil, Keith D., MD, Wlodarczyk, John, MD, Gabbay, Eli, MD, Williams, Trevor J., MD

    “…Background Bosentan (an oral dual endothelin receptor antagonist) improves symptoms and cardiac hemodynamics and reduces clinical worsening in patients with…”
    Get full text
    Journal Article
  14. 14

    Interstitial lung disease in recent onset rheumatoid arthritis by GABBAY, E, TARALA, R, WILL, R, CARROLL, G, ADLER, B, CAMERON, D, LAKE, F. R

    “…Interstitial lung disease (ILD) is associated with rheumatoid arthritis (RA); however, the prevalence and natural history are undefined. Our aim was to…”
    Get full text
    Journal Article
  15. 15

    Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial by Ganderton, Louise, Jenkins, Sue, Gain, Kevin, Fowler, Robin, Winship, Peta, Lunt, Dianne, Gabbay, Eli

    Published in BMC pulmonary medicine (23-05-2011)
    “…Advances in the understanding and management of pulmonary arterial hypertension have enabled earlier diagnosis and improved prognosis. However, despite best…”
    Get full text
    Journal Article
  16. 16

    Maximizing the Utilization of Donor Organs Offered for Lung Transplantation by GABBAY, ELI, WILLIAMS, TREVOR J, GRIFFITHS, ANNE P, MACFARLANE, LOUISE M, KOTSIMBOS, TOM C, ESMORE, DONALD S, SNELL, GREGORY I

    “…The number of patients awaiting lung transplantation (LT) and waiting time for surgery is increasing. In Australia, LT rates are 4. 6/million population/yr,…”
    Get full text
    Journal Article
  17. 17

    Effects of High-Intensity Inspiratory Muscle Training Following a Near-Fatal Gunshot Wound by Hill, Kylie, Gain, Kevin R, McKay, Sean W, Nathan, Christine, Gabbay, Eli

    Published in Physical therapy (01-09-2011)
    “…Severe injuries sustained during combat may classify individuals as undeployable for active service. It is imperative that every effort is made to optimize…”
    Get full text
    Journal Article
  18. 18

    Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy? by Steele, Peter, Strange, Geoff, Wlodarczyk, John, Dalton, Brad, Stewart, Simon, Gabbay, Eli, Keogh, Anne

    Published in BMC cardiovascular disorders (22-02-2010)
    “…Pulmonary arterial hypertension (PAH) has witnessed dramatic treatment advances over the past decade. However, with the exception of epoprostenol, data from…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort by Strange, Geoff, Playford, David, Stewart, Simon, Deague, Jenny A, Nelson, Helen, Kent, Aaron, Gabbay, Eli

    Published in Heart (British Cardiac Society) (01-12-2012)
    “…Pulmonary hypertension (PHT) lacks community prevalence and outcome data. To characterise minimum 'indicative' prevalences and mortality data for all forms of…”
    Get more information
    Journal Article